BSECompany Update8h ago · 25 Sept 2026, 10:55 am

Mangalam Drugs and Organics Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left">&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Mangalam Drugs and Organics Limited · 532637

✦ AI Summary

Mangalam Drugs and Organics Limited has informed BSE about the completion of tenure of its Statutory Auditor, XBRL.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mangalam Drugs and Organics Limited-532637- Tenure completion Statutory Auditor - XBRL